Home › Funds › GREAT POINT PARTNERS LLC › ABCL
GREAT POINT PARTNERS LLC position in ABCL
ABCELLERA BIOLOGICS INC · Health Care
GREAT POINT PARTNERS LLC reported holding 600,000 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q3 2026 13F filing — a position valued at US$8.8M, representing 2.19% of its reported portfolio and ranking #19 among its reported holdings. GREAT POINT PARTNERS LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How GREAT POINT PARTNERS LLC's ABCL position evolved
GREAT POINT PARTNERS LLC first disclosed a stake in ABCL in Q3 2026 at 600,000 shares (US$8.8M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 600.00K | $8.75M | New |
About ABCL and 13F data
ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 46 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$481.6M), ArrowMark Colorado Holdings LLC (US$70.4M), ADAR1 Capital Management, LLC (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABCL
- BAKER BROS. ADVISORS LP 33.01M sh · $481.65M · Q3 2026
- ArrowMark Colorado Holdings LLC 4.82M sh · $70.37M · Q3 2026
- ADAR1 Capital Management, LLC 822.16K sh · $12.00M · Q3 2026
- Guardian Partners Inc. 596.00K sh · $8.70M · Q3 2026
- Intellectus Partners, LLC 584.13K sh · $8.52M · Q3 2026
- Informed Momentum Co LLC 446.19K sh · $6.51M · Q3 2026
- Global IMC LLC 278.90K sh · $4.07M · Q3 2026
More on GREAT POINT PARTNERS LLC
FAQ
How long has GREAT POINT PARTNERS LLC held ABCL?
GREAT POINT PARTNERS LLC has disclosed ABCL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is GREAT POINT PARTNERS LLC's current position in ABCL?
As of Q3 2026, GREAT POINT PARTNERS LLC holds 600.00K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $8.75M, representing 2.19% of its reported portfolio and ranking #19.
Has GREAT POINT PARTNERS LLC been buying or selling ABCL?
In the latest 13F filing (Q3 2026), GREAT POINT PARTNERS LLC newly opened its position in ABCL.
Which other funds hold ABCL?
Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, ADAR1 Capital Management, LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.